Target intelligence / Profile preview

IgLON family member 5 (IGLON5)

Target
IGLON5
Molecular classification
Immunoglobulin superfamily, Cell adhesion molecule, GPI-anchored membrane protein
01

Overview

IgLON family member 5 is a glycosylphosphatidylinositol (GPI)-anchored cell surface protein of the immunoglobulin superfamily, found primarily in neurons and oligodendrocytes but also expressed in skeletal muscle and some non-neural tissues[1][2][3][4]. Like other IgLONs, it forms homophilic or heterophilic complexes and is essential for cell adhesion, neuronal migration, axon guidance, and muscle cell differentiation and regeneration[1][2][3]. Pathogenic autoantibodies targeting IgLON5 underlie anti-IgLON5 disease, a rare neurodegenerative tauopathy characterized by sleep disorders and neuronal cytoskeletal pathology, suggesting a crucial, multifaceted role in nervous system and muscle integrity[3][4]. There are currently no approved drugs targeting IgLON5 directly; however, IgLON5 antibodies serve as important diagnostic biomarkers for the corresponding autoimmune syndrome[3][4][1].

Other names
IGLON5LOC402665Ig-like domain-containing protein ENSP00000270642hCG1651476igLON5
02

Biological functions

Cell adhesionRegulation of myogenesis/muscle regenerationNeurite outgrowth and axonal guidanceNeuronal cell migration
03

Disease associations

Neurodegenerative disease (specifically, anti-IgLON5 disease, a tauopathy)Psychiatric disordersPotential tumor suppressor in some non-neural tissues
04

Safety considerations

IgLON5 autoimmunity can induce an irreversible internalization of membrane IgLON5 and is implicated in neurodegeneration, particularly with sleep dysfunction and tauopathy
05

Biomarkers

Anti-IgLON5 autoantibodies (as biomarkers for anti-IgLON5 disease)

Beyond the preview

Go deeper on IgLON family member 5 (IGLON5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on IgLON family member 5 (IGLON5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call